Mark Stenhouse
No shares they bought or sold themselves in the last 12 months. Their newest Form 4, for May 19: stock award (24,122 PHAT shares).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade Mark Stenhouse reported
None in the last 12 months, as filed.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Mark Stenhouse's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 0 |
Alerts for Mark Stenhouse
Use this page
How to cite
Breakaway, Mark Stenhouse: Director at Phathom Pharmaceuticals (PHAT), May 19, 2026, getbreakaway.com/insiders/mark-stenhouse
Journalists: email support@getbreakaway.com for the data behind this page.